Przedsiębiorstwo Farmaceutyczne Sulphur Zdrój Eximsp. z o.o.
Manufacture of pharmaceutical preparations
Overview
Przedsiębiorstwo Farmaceutyczne Sulphur Zdrój Exim is a producer of therapeutic products, specializing in treatments using sulfur brine and peat extracts. The company offers over-the-counter medications and wellness cosmetics, particularly for joint pain relief and rehabilitation. Additionally, they provide services related to health treatments in a spa-like environment.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2019-07-01. Active
89 2490 0005 0000 4530 3295 2096
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
9 public aid cases recorded, with a total value of $45,751.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Oct 18, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $9,020$9,020 | Prezes Banku Gospodarstwa Krajowego | |
| Feb 22, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $10,767$10,767 | Prezes Banku Gospodarstwa Krajowego | |
| Apr 2, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $3,450$3,450 | Prezes Banku Gospodarstwa Krajowego |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2017-03-15 | Rozszerzenie produkcji o nowy produkt kosmetyczny w wyniku badań laboratoryjnych | $202.8K$202,848 | Regionalny Program Operacyjny Województwa Świętokrzyskiego na lata 2014-2020 |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a multi-member management board, in matters of ordinary management with a value not exceeding PLN 100,000.00 (one hundred thousand złotys), each member of the management board may submit declarations and represent the company independently. The joint action of two members of the management board is required to represent the company and submit declarations on its behalf in matters with a value exceeding PLN 100,000.00 (one hundred thousand złotys).
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 35,000 | $945,434.90 | 100% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Agnieszka Krysik (43)  | Other natural person. | |
Henryk Orfinger (75) | Other natural person. | |
Krzysztof Orfinger (34) | Other natural person. | |
Irena Szołomicka-Orfinger (76) | Other natural person. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Produkcyjno-Handlowe EwaS.A. | $14,322,437.53 | ewa-sa.pl | ||
| Labofarmsp. z o.o. | $6,814,569.78 | labofarm.pl | ||
| Przedsiębiorstwo Farmaceutyczne Leki Natury Tadeusz Polańskisp. z o.o. | $893,738.50 | lekinatury.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-06-25 | Share capital change (2,700,000.00 PLN → 3,500,000.00 PLN) | |
| 2020-02-26 | PKD change (Removed: 17.21.Z; Added: 47.91.Z) | |
| 2019-07-01 | Entered in the register |
FAQ
Last updated: 2026-06-25